Salt Lake City, UT, United States of America

Eric Delmar


Average Co-Inventor Count = 6.5

ph-index = 4

Forward Citations = 63(Granted Patents)


Company Filing History:


Years Active: 1998-2009

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Eric Delmar: Innovator in Pharmaceutical Compounds

Introduction

Eric Delmar is a notable inventor based in Salt Lake City, UT (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 4 patents. His work primarily focuses on compounds and compositions that have therapeutic applications.

Latest Patents

Delmar's latest patents include innovative compounds and pharmaceutical compositions that are useful in the therapeutic treatment or prevention of various diseases. One of his notable inventions is related to metabotropic glutamate receptor antagonists, which are designed for treating central nervous system diseases. This invention provides compounds and pharmaceutical compositions that are active at metabotropic glutamate receptors, offering potential solutions for neurological diseases and disorders. Methods of preparing these compounds are also disclosed in his patents.

Career Highlights

Throughout his career, Eric Delmar has worked with prominent companies such as NPS Pharmaceuticals, Inc. and FMC Corporation. His experience in these organizations has allowed him to develop and refine his innovative ideas in the pharmaceutical sector.

Collaborations

Delmar has collaborated with several professionals in his field, including Bradford C. Van Wagenen and Scott T. Moe. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Eric Delmar's contributions to pharmaceutical innovations highlight his expertise and dedication to improving therapeutic treatments. His patents reflect a commitment to addressing significant health challenges through innovative solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…